{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:13:32Z","timestamp":1793722412036,"version":"4.6.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020797","name":"NanoMedicines Innovation Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000521","name":"Canadian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001260","name":"National Organization for Rare Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001260","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jconrel.2024.06.041","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T10:10:32Z","timestamp":1719310232000},"page":"362-371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Resiquimod-loaded cationic liposomes cure mice with peritoneal carcinomatosis and induce specific anti-tumor immunity"],"prefix":"10.1016","volume":"372","author":[{"given":"Po-Han","family":"Chao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas J.","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyh-Dar","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.06.041_bb0005","doi-asserted-by":"crossref","DOI":"10.5114\/pjr.2023.125027","article-title":"Diagnosis and treatment of peritoneal carcinomatosis \u2013 a comprehensive overview","volume":"88","author":"Szadkowska","year":"2023","journal-title":"Pol. J. Radiol."},{"key":"10.1016\/j.jconrel.2024.06.041_bb0010","article-title":"Peritoneal cancer, the APRN and PA\u2019s complete guide to prescribing","author":"Anwar","year":"2022","journal-title":"Drug Therapy"},{"key":"10.1016\/j.jconrel.2024.06.041_bb0015","first-page":"123","article-title":"Immune niche within the peritoneal cavity","volume":"434","author":"Okabe","year":"2021","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.041_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.868695","article-title":"The evasion mechanisms of cancer immunity and drug intervention in the tumor microenvironment","volume":"13","author":"Kim","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.06.041_bb0025","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.4161\/onci.21176","article-title":"Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growth","volume":"1","author":"Fujimura","year":"2012","journal-title":"Oncoimmunology"},{"issue":"2018","key":"10.1016\/j.jconrel.2024.06.041_bb0030","first-page":"1350","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.06.041_bb0035","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.15252\/emmm.201607485","article-title":"Clinical development of CAR T cells\u2014challenges and opportunities in translating innovative treatment concepts","volume":"9","author":"Hartmann","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jconrel.2024.06.041_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082383","article-title":"Immunotherapy for peritoneal carcinomatosis: challenges and prospective outcomes","volume":"15","author":"Ornella","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2024.06.041_bb0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2012\/103298","article-title":"Toll-like receptor 7 agonist therapy with imidazoquinoline enhances cancer cell death and increases lymphocytic infiltration and proinflammatory cytokine production in established tumors of a renal cell carcinoma mouse model","volume":"2012","author":"Kauffman","year":"2012","journal-title":"J. Oncol."},{"key":"10.1016\/j.jconrel.2024.06.041_bb0055","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jconrel.2023.12.007","article-title":"Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy","volume":"365","author":"Dang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.06.041_bb0060","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.vaccine.2014.02.027","article-title":"Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release","volume":"32","author":"Ilyinskii","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2024.06.041_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1168252","article-title":"Imidazoquinolines with improved pharmacokinetic properties induce a high IFN\u03b1 to TNF\u03b1 ratio in vitro and in vivo","volume":"14","author":"Keppler","year":"2023","journal-title":"Front. Immunol."},{"issue":"29","key":"10.1016\/j.jconrel.2024.06.041_bb0070","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/onc.2009.356","article-title":"Immunogenic death of colon cancer cells treated with oxaliplatin","volume":"4","author":"Tesniere","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2024.06.041_bb0075","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2817","article-title":"Generation of luciferase-expressing tumor cell lines","volume":"8","author":"Brennan","year":"2018","journal-title":"Bio-Protoc."},{"key":"10.1016\/j.jconrel.2024.06.041_bb0080","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1690-2","article-title":"Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy","volume":"15","author":"Tsang","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jconrel.2024.06.041_bb0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2018.03.004","article-title":"Systemic study of solvent-assisted active loading of gambogic acid into liposomes and its formulation optimization for improved delivery","volume":"166","author":"Tang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.06.041_bb0090","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/iej.13965","article-title":"Intracellular bacterial eradication using a novel peptide in vitro","volume":"56","author":"Ng","year":"2023","journal-title":"Int. Endod. J."},{"key":"10.1016\/j.jconrel.2024.06.041_bb0095","article-title":"The Yin and Yang of type I IFNs in cancer promotion and immune activation","volume":"10","author":"Musella","year":"2021","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.jconrel.2024.06.041_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00219","article-title":"Cognate interaction with CD4+ T cells instructs tumor-associated macrophages to acquire M1-like phenotype","volume":"10","author":"Eisel","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.041_bb0105","doi-asserted-by":"crossref","first-page":"26771","DOI":"10.18632\/oncotarget.15816","article-title":"Tumor regression is mediated via the induction of HER263-71- specific CD8+ CTL activity in a 4T1.2\/HER2 tumor model: no involvement of CD80 in tumor control","volume":"8","author":"Danishmalik","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2024.06.041_bb0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coi.2021.09.005","article-title":"The role of CD4 T cells in rejection of solid tumors","volume":"74","author":"Poncette","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2024.06.041_bb0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/jitc-2021-004001","article-title":"Original research: ascites and resistance to immune checkpoint inhibition in dMMR\/MSI-H metastatic colorectal and gastric cancers","volume":"10","author":"Fuc\u00e0","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2024.06.041_bb0120","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.immuni.2018.09.024","article-title":"Successful anti-PD-1 cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-\u03b3 and IL-12","volume":"49","author":"Garris","year":"2018","journal-title":"Immunity"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924003900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924003900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T19:30:46Z","timestamp":1721935846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924003900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":23,"alternative-id":["S0168365924003900"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.06.041","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resiquimod-loaded cationic liposomes cure mice with peritoneal carcinomatosis and induce specific anti-tumor immunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.06.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}